Creative Medical Technology Holdings, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Creative Medical Technology Holdings, Inc. (CELZ) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$564.89 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-11-07
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $1.76M, a 68.19% decline year-over-year.
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $5.54M, a 363.38% increase year-over-year.
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $1.20M.
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-03-31 was -$1.58M, a 990.29% decline year-over-year.
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $2.47M.
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$4.85M.
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$2.40M, a 122.62% decline from fiscal 2021.
- Creative Medical Technology Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was $10.63M, a 113375.63% increase from fiscal 2020.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | -$564.89K 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | $603.72K 10-Q · filed 2025-08-08 | ||||
| 2025-03-31 | $1.76M 10-Q · filed 2025-05-09 | ||||
| 2024-12-31 | $2.47M 10-K · filed 2025-03-14 | ||||
| 2024-09-30 | $2.79M 10-Q · filed 2025-11-07 | ||||
| 2024-06-30 | $4.00M 10-Q · filed 2025-08-08 | ||||
| 2024-03-31 | $5.54M 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | -$4.85M 10-K · filed 2025-03-14 | ||||
| 2023-09-30 | -$3.81M 10-Q · filed 2024-11-08 | -$3.71M 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | -$4.33M 10-Q · filed 2024-08-09 | ||||
| 2023-03-31 | $1.20M 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | -$2.40M 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $6.25M 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $12.14M 10-Q · filed 2023-08-11 | ||||
| 2022-03-31 | -$1.58M 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $10.63M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $2.28M 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | $60.58K 10-Q · filed 2022-08-12 | ||||
| 2021-03-31 | $177.12K 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | $9.36K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |